
Vasc-Alert is a technology company that provides surveillance for hemodialysis vascular access. Their patented system uses existing patient treatment data to monitor intra-access pressures, alerting staff to potential issues without manual testing. This subscription-based service enhances patient outcomes and operational efficiency for dialysis centers, reducing complications and improving financial performance. With FDA approval since 2003, Vasc-Alert has established a strong market presence and continues to innovate in vascular access management.

Vasc-Alert is a technology company that provides surveillance for hemodialysis vascular access. Their patented system uses existing patient treatment data to monitor intra-access pressures, alerting staff to potential issues without manual testing. This subscription-based service enhances patient outcomes and operational efficiency for dialysis centers, reducing complications and improving financial performance. With FDA approval since 2003, Vasc-Alert has established a strong market presence and continues to innovate in vascular access management.
Product: FDA-cleared subscription vascular access surveillance for hemodialysis
Founded: 2002
Customers: Used by hundreds of U.S. dialysis centers (clinically validated)
Funding: Seed round listed Dec 7, 2022; disclosed total funding $500,000 (USD)
Team size: 8 employees
Vascular access surveillance for hemodialysis centers
2002
Healthcare
500000.00